Clinical Trials Of A Second Russian Coronavirus Vaccine Have Proved Successful: Report
Vektor said it would be possible to make the final conclusions about the efficacy of its vaccine, based on peptides that trigger an immune response, after post-approval clinical trials have been completed.
After Russia boasted of approving the world's first vaccine, there seems to be a second COVID-19 vaccine in line.
Russia¡¯s Vector, a top-secret state virology research centre in Siberia, said that early-stage trials were successful for its own experimental vaccine, named EpiVacCorona.
"The first two phases of clinical trials demonstrated the effectiveness and safety of the EpiVacCorona vaccine," Vecctor's press department told the Interfax news agency.
Image For Representation
Vector said it would be possible to make the final conclusions about the efficacy of its vaccine, based on peptides that trigger an immune response, after post-approval clinical trials have been completed.
Russian Health Minister, Mikhail Murashko, told President Vladimir Putin this week, that Vector's vaccine could be approved by the ministry in three weeks.
Vector said post-registration clinical trials would begin
on 5,000 volunteers in Siberia. The lab said there would be a separate clinical trial
involving 150 volunteers who are over 60 years of age.
Image For Representation/AFP
After that Vector will begin placebo-controlled trials on 5,000 Russian volunteers between the ages of 18 and 60.
Also Read: Russia Received Requests To Supply 1.2 Billion Dozes Of 'Sputnik V' COVID-19 Vaccine
The EpiVacCorona vaccine is a two-component vaccine, and the interval between the administration of the first and second components is 21 days.
Russia plans to manufacture an initial 10,000 doses, Vector said, with production expected to begin in November.
Vector declined to comment when contacted by AFP and referred all queries to Rospotrebnadzor, the country's consumer safety watchdog.
Reuters
Russia announced in August that it had developed the world's first registered vaccine "Sputnik V", named after the world's first satellite.
Also Read: COVID-19 Vaccine: Russia Signs Deal With Dr Reddy's For Trial & Distribution Of Sputnik V In India
It raised concerns among Western scientists after it received approval before full clinical trials were completed.
While there have been several different types of treatments being given to COVID-19 patients across the world, there isn¡¯t any one drug that has worked as a sure-shot treatment yet. Don¡¯t self medicate/stock up and always consult your doctor/medical health professional.
